转谷氨酰胺酶1（TGM1）可以预测膀胱癌患者的总生存期。 - Suppr | 超能文献

文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

转谷氨酰胺酶1（TGM1）可以预测膀胱癌患者的总生存期。 - Suppr | 超能文献

TGM1 could predict overall survival for patients with urinary bladder cancer.

作者信息

Wang Jie, Xiao Yuhan, Wu Ruicheng, Zhang Chi

机构信息

Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; West China School of Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.

Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, PR China.

出版信息

Asian J Surg. 2023 Nov;46(11):5373-5375. doi: 10.1016/j.asjsur.2023.07.102. Epub 2023 Sep 6.

DOI:10.1016/j.asjsur.2023.07.102

Abstract

摘要

相似文献

1

TGM1 could predict overall survival for patients with urinary bladder cancer.转谷氨酰胺酶1（TGM1）可以预测膀胱癌患者的总生存期。

Asian J Surg. 2023 Nov;46(11):5373-5375. doi: 10.1016/j.asjsur.2023.07.102. Epub 2023 Sep 6.

2

Recent Developments in the Search for Urinary Biomarkers in Bladder Cancer.膀胱癌尿液生物标志物研究的最新进展

Curr Urol Rep. 2017 Nov 13;18(12):100. doi: 10.1007/s11934-017-0748-x.

3

Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups.原发性浅表性膀胱肿瘤后的上尿路肿瘤：预后因素和风险组

J Urol. 2000 Oct;164(4):1183-7.

4

Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA.临床参数在预测膀胱癌预后方面优于分子亚型：来自多个队列的结果，包括 TCGA。

J Urol. 2020 Jan;203(1):62-72. doi: 10.1097/JU.0000000000000351. Epub 2019 May 21.

5

[Upper urinary tract tumors following bladder cancer].[膀胱癌继发上尿路肿瘤]

Nihon Hinyokika Gakkai Zasshi. 1990 Sep;81(9):1362-6. doi: 10.5980/jpnjurol1989.81.1362.

6

Survival of patients with urinary bladder cancer in Jordan, 2005-2014.2005-2014 年约旦膀胱癌患者的生存情况。

East Mediterr Health J. 2021 Jul 29;27(7):648-655. doi: 10.26719/2021.27.7.648.

7

Significant impact of a history of prior or concomitant upper urinary tract cancer on the recurrence and progression of non-muscle invasive bladder cancer.既往或同时存在上尿路尿路上皮癌对上尿路尿路上皮癌复发和进展的显著影响。

Jpn J Clin Oncol. 2022 Aug 5;52(8):944-949. doi: 10.1093/jjco/hyac068.

8

Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.根治性肾输尿管切除术治疗上尿路上皮癌后既往、同期或随后膀胱癌对预后的影响。

J Urol. 2019 Dec;202(6):1127-1135. doi: 10.1097/JU.0000000000000422. Epub 2019 Jun 28.

9

Does Health Insurance Modify the Association Between Race and Cancer-Specific Survival in Patients with Urinary Bladder Malignancy in the U.S.?医疗保险是否能改变美国膀胱癌患者中种族与癌症特异性生存之间的关联？

Int J Environ Res Public Health. 2019 Sep 13;16(18):3393. doi: 10.3390/ijerph16183393.

10

Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study.肿瘤位置可能预测膀胱癌根治性治疗后的不良病理和生存：一项全国性队列研究。

Eur Urol Oncol. 2019 May;2(3):304-310. doi: 10.1016/j.euo.2018.08.018. Epub 2018 Sep 14.

引用本文的文献

1

A pan-cancer analysis of the oncogenic and immunological roles of transglutaminase 1 (TGM1) in human cancer.转谷氨酰胺酶1（TGM1）在人类癌症中的致癌和免疫作用的泛癌分析

J Cancer Res Clin Oncol. 2024 Mar 12;150(3):123. doi: 10.1007/s00432-024-05640-6.